Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | DBD Diebold Nixdorf Incorporated | AMPX Amprius Technologies, Inc. |
|---|---|---|
| Price | $63.49 -2.2% | $9.54 +4.8% |
| StockIQ Score | 46D+ Moderate Risk: Medium | 42D Weak Risk: High |
| Technical | 19F | 13F |
| Fundamental | 43D | 27F |
| Growth | 68B- | 70B |
| Fair Value | 50C- | 38F |
| News | 62C+ | 92A+ |
| Quality | 58C | 58C |
| Risk | 50C- | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Amprius (AMPX) outperforms Diebold Nixdorf (DBD) in growth, scoring 70 versus 68, indicating stronger expected expansion. However, DBD leads in overall investor confidence with a score of 51 compared to AMPX’s 43, and its valuation score of 50 is higher than AMPX’s 38. DBD also has better technical and fundamental scores, making it stronger in most categories.